Susquehanna International Group’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,673,500
| Closed | -$265M | – | 11309 |
|
|
2019
Q3 | $265M | Sell |
2,673,500
-28,800
| -1% | -$2.74M | 0.09% | 188 |
|
|
2019
Q2 | $250M | Sell |
2,702,300
-1,853,700
| -41% | -$176M | 0.09% | 179 |
|
|
2019
Q1 | $430M | Sell |
4,556,000
-489,500
| -10% | -$42.8M | 0.18% | 83 |
|
|
2018
Q4 | $323M | Buy |
5,045,500
+903,000
| +22% | +$66.7M | 0.13% | 126 |
|
|
2018
Q3 | $371M | Sell |
4,142,500
-2,635,200
| -39% | -$233M | 0.12% | 122 |
|
|
2018
Q2 | $538M | Buy |
6,777,700
+96,900
| +1% | +$8.05M | 0.18% | 73 |
|
|
2018
Q1 | $596M | Buy |
6,680,800
+2,405,100
| +56% | +$231M | 0.21% | 62 |
|
|
2017
Q4 | $446M | Buy |
4,275,700
+1,868,800
| +78% | +$211M | 0.16% | 89 |
|
|
2017
Q3 | $351M | Sell |
2,406,900
-64,400
| -3% | -$8.77M | 0.14% | 113 |
|
|
2017
Q2 | $321M | Buy |
2,471,300
+465,300
| +23% | +$57M | 0.14% | 108 |
|
|
2017
Q1 | $250M | Buy |
2,006,000
+353,200
| +21% | +$42.3M | 0.13% | 132 |
|
|
2016
Q4 | $191M | Sell |
1,652,800
-286,400
| -15% | -$31.9M | 0.1% | 179 |
|
|
2016
Q3 | $203M | Buy |
1,939,200
+15,600
| +0.8% | +$1.69M | 0.1% | 160 |
|
|
2016
Q2 | $190M | Sell |
1,923,600
-56,300
| -3% | -$5.82M | 0.1% | 166 |
|
|
2016
Q1 | $198M | Sell |
1,979,900
-1,757,600
| -47% | -$181M | 0.11% | 146 |
|
|
2015
Q4 | $448M | Sell |
3,737,500
-1,233,700
| -25% | -$143M | 0.21% | 77 |
|
|
2015
Q3 | $538M | Buy |
4,971,200
+353,700
| +8% | +$43.9M | 0.23% | 58 |
|
|
2015
Q2 | $534M | Sell |
4,617,500
-637,900
| -12% | -$72.9M | 0.23% | 54 |
|
|
2015
Q1 | $606M | Sell |
5,255,400
-21,800
| -0.4% | -$2.6M | 0.27% | 39 |
|
|
2014
Q4 | $590M | Buy |
5,277,200
+28,200
| +0.5% | +$2.97M | 0.23% | 58 |
|
|
2014
Q3 | $498M | Buy |
5,249,000
+101,000
| +2% | +$9.11M | 0.19% | 72 |
|
|
2014
Q2 | $442M | Sell |
5,148,000
-767,800
| -13% | -$58.4M | 0.19% | 70 |
|
|
2014
Q1 | $413M | Buy |
5,915,800
+1,803,400
| +44% | +$143M | 0.19% | 71 |
|
|
2013
Q4 | $347M | Buy |
4,112,400
+671,200
| +20% | +$53.1M | 0.16% | 87 |
|
|
2013
Q3 | $265M | Sell |
3,441,200
-332,400
| -9% | -$23.3M | 0.14% | 96 |
|
|
2013
Q2 | $221M | Buy |
+3,773,600
| New | +$227M | 0.13% | 109 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Susquehanna International Group's CELG Position: Q4 2019 in Review
Susquehanna International Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,651,500 shares — an estimated $164M sold.
Susquehanna International Group first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $353M in Q1 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Susquehanna International Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Susquehanna International Group sold 1,651,500 Celgene Corp shares in Q4 2019, an estimated $164M.
- Susquehanna International Group first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Susquehanna International Group's Celgene Corp position peaked at $353M in Q1 2018.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Susquehanna International Group's 13F filing for Q4 2019, filed 14 Feb 2020.